Health-eBrain Study (HeB)
29. juni 2018 opdateret af: AnthroTronix, Inc.
Caregivers Virtual Health eBrain Study II
The purposes of this study are to (1) track dementia caregiver health indicators over 12 weeks, both with and without the Mindoula plus DANA intervention (case manager and mobile messaging and assessment applications) to determine if the intervention improves caregiver health and (2) obtain feedback from caregivers to inform on the design of future interventions.
Studieoversigt
Status
Trukket tilbage
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This study will track the mental status and cognition of caregivers with and without the Mindoula and DANA intervention and use subject feedback to aid in designing future interventions for caregivers.
This is a remotely administered, virtual study targeting dementia caregivers who are mild to moderately depressed. Screening calls for online administration of four surveys to determine inclusion in the study arms. These surveys will be taken on the Health-eBrain website, both at baseline/screening and throughout participation. All other participation will be completed on the participant's mobile phone, and all psychological and cognitive tests will be self-administered.
This study has a between-group design. Participants will be screened for eligibility and then randomized into each arm. The intervention arm will receive the Mindoula plus DANA intervention. The wait list control arm will take the psychological surveys at regular intervals then, after 12 weeks, be enrolled in the DANA-only observation group. The DANA-only group will take DANA and a usability questionnaire.
Undersøgelsestype
Interventionel
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Maryland
-
Silver Spring, Maryland, Forenede Stater, 20910
- AnthroTronix Inc
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
45 år til 75 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Females and males who regularly provide care for a person with Alzheimer's Disease
- Between the ages of 45-75
- Self-reported ability to speak and read English
- Providing care for at least a year
Participants in the Intervention and Waitlist Control Arms must meet the following additional inclusion criteria:
- Zarit Burden Inventory (ZBI) Score of 9+
- Overall M3 score of 33+
- M3 Depression score of 7+
- Female Only
- Minimum hours of caregiving a week must be equal to or greater than 20 hours
Exclusion Criteria:
- Anyone with a known cognitive diagnosis
- Anyone with color blindness
- Overall score of high risk on the M3 and/or high risk on the PTSD or Bipolar subsection of the M3
- Failure to meet all inclusion criteria per arm
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Intervention Arm
Participants will receive the intervention, Mindoula plus DANA, which involves working with a case manager via an app for 12 weeks.
The case manager will help the participant cope with the stresses of caregiving as well as remind them to use the DANA cognitive assessment app.
This arm will also take the study's psychological surveys.
|
The Mindoula intervention is a combination of case management and a messenger application.
Case managers monitor how the participant is doing and any needs and provide 24/7 support & assistance, including care coordination, treatment adherence, and matching the participant with providers and community resources.
Each participant will be given an intake questionnaire to establish goals and behavioral health history.
Participants will use the app and work with the case manager for 12 weeks.
DANA is an FDA-cleared neurocognitive assessment software administered on a smartphone or tablet to measure changes in cognitive efficiency.
DANA also includes Ecological Momentary Assessments to track mood, sleep, stress, and memory.
Intervention participants will take DANA weekly.
The Waitlist Control arm will take DANA weekly 12 weeks after enrollment.
|
|
Andet: Waitlist Control Arm
These participants will take psychological surveys and a usability questionnaire for the first 12 weeks of participation, then, for the 12 weeks following, take the psychological surveys along with DANA and a usability questionnaire.
|
DANA is an FDA-cleared neurocognitive assessment software administered on a smartphone or tablet to measure changes in cognitive efficiency.
DANA also includes Ecological Momentary Assessments to track mood, sleep, stress, and memory.
Intervention participants will take DANA weekly.
The Waitlist Control arm will take DANA weekly 12 weeks after enrollment.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Change from baseline M3 Behavioral Scale score over 12 weeks
Tidsramme: At baseline, and 4, 8, and 12 weeks.
|
At baseline, and 4, 8, and 12 weeks.
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Change from baseline Zarit Burden Inventory score over 12 weeks
Tidsramme: At baseline, and 4, 8, and 12 weeks.
|
At baseline, and 4, 8, and 12 weeks.
|
|
Change from baseline PROMIS Sleep Disturbance Short Form 8a score over 12 weeks
Tidsramme: At baseline, and 4, 8, and 12 weeks.
|
At baseline, and 4, 8, and 12 weeks.
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Usability Questionnaire
Tidsramme: At baseline, and 4, 8, and 12 weeks.
|
Survey on using DANA that will help the researchers better understand the development of technologies for this population
|
At baseline, and 4, 8, and 12 weeks.
|
|
Paired Associates Learning
Tidsramme: At baseline and 12 weeks
|
The PAL assesses visual memory and new learning.
|
At baseline and 12 weeks
|
|
PERMA Profiler
Tidsramme: At baseline and 12 weeks
|
This survey assesses five core element of psychological well-being and happiness - Positive emotions, Engagement, Relationships, Meaning, and Accomplishments - as well as subjective wellbeing and sense of loneliness.
|
At baseline and 12 weeks
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Corinna E Lathan, Ph.D, AnthroTronix, Inc.
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
1. juli 2016
Primær færdiggørelse (Faktiske)
1. juli 2017
Studieafslutning (Faktiske)
1. juli 2017
Datoer for studieregistrering
Først indsendt
3. august 2016
Først indsendt, der opfyldte QC-kriterier
13. september 2016
Først opslået (Skøn)
16. september 2016
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
3. juli 2018
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
29. juni 2018
Sidst verificeret
1. juni 2018
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 091614A
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Depression and Burden in Caregivers
-
University Hospital, GrenobleSociété Française d'Anesthésie et de RéanimationAfslutteteFast Diagnosis Performance in Guiding First Aid Resuscitation and HemostasisFrankrig
-
Tel-Aviv Sourasky Medical CenterUkendtDepression | Angst | In vitro befrugtningIsrael
-
University of WashingtonNational Cancer Institute (NCI)AfsluttetDepression | Fase II brystkræft | Stadie IIIA brystkræft | Stadie IIIB brystkræft | Angst lidelse | Psykosociale virkninger af kræft og dens behandling | Stadie IA brystkræft | Stadie IB brystkræft | Stadie IIIC brystkræft | Duktalt brystcarcinom in situ | Lobulært brystcarcinom in situForenede Stater
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)AfsluttetDepression | Træthed | Fase II brystkræft | Stadie IIIA brystkræft | Stadie IIIB brystkræft | Angst lidelse | Stadie IA brystkræft | Stadie IB brystkræft | Stadie IIIC brystkræft | Duktalt brystcarcinom in situForenede Stater
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)AfsluttetDepression | Brystkræft | Angst lidelse | Psykosociale virkninger af kræft og dens behandlingForenede Stater